(Reuters) — Indian generic drugmaker Ranbaxy Laboratories Ltd. has been sued in U.S. District Court for allegedly manipulating U.S. Food and Drug Administration rules for years to keep rival generic drugs out of the market.
(Reuters) — Indian generic drugmaker Ranbaxy Laboratories Ltd. has been sued in U.S. District Court for allegedly manipulating U.S. Food and Drug Administration rules for years to keep rival generic drugs out of the market.